Fairmount Funds Management LLC Karyopharm Therapeutics Inc. Transaction History

Fairmount Funds Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.85 - $17.69 $6.92 Million - $12.4 Million	-702,351 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$14.14 - $19.71 $707,000 - $985,500	50,000 Added 7.66%	702,351 $10.3 Million
Q2 2020 Aug 04, 2020	BUY	$16.6 - $25.25 $1.49 Million - $2.27 Million	90,000 Added 16.0%	652,351 $12.4 Million
Q1 2020 May 08, 2020	BUY	$14.38 - $27.72 $2.31 Million - $4.46 Million	160,742 Added 40.02%	562,351 $10.8 Million
Q4 2019 Feb 12, 2020	BUY	$9.23 - $19.67 $3.71 Million - $7.9 Million	401,609 New	401,609 $7.7 Million

120

72.4M

476K

175K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $66.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.